Status:
NOT_YET_RECRUITING
Evaluate Cytotoxicity, Leaching, and Structural Conformation of Clear Aligners
Lead Sponsor:
Riyadh Elm University
Conditions:
Malocclusion
Cytotoxicity
Eligibility:
All Genders
21-40 years
Phase:
PHASE4
Brief Summary
The aim is to evaluate clear aligners' cytotoxicity, leaching, and structural properties and compare them with four cleaning tools. The null hypothesis is the cleansers have no impact on the propertie...
Detailed Description
Orthodontic Invisalign clear aligners patients will be randomly distributed into four groups using four cleaning methods. Participants will be instructed to clean their trays as instructed by the prod...
Eligibility Criteria
Inclusion
- Participants who are on Invisalign Clear aligner treatment.
- Participants who are 21 years and older and committed to their treatment.
- Participants with caries-free dentition
- Participants with no smoking habits
- Participants are not pregnant females
Exclusion
- Participants who are on Orthognathic treatment.
- Participants with Hypodontia.
Key Trial Info
Start Date :
July 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 5 2025
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT06503029
Start Date
July 15 2024
End Date
March 5 2025
Last Update
July 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Riyadh Elm University
Riyadh, Saudi Arabia, 12611